Oncology
-
Pietenpol to receive American Society of Clinical Oncology’s highest honor
Jennifer Pietenpol, Ingram Professor of Cancer Research and professor of biochemistry, is the 2024 recipient of the Science of Oncology Award, which is presented annually to an individual who has made outstanding contributions to basic or translational research in cancer. Read MoreApr 17, 2024
-
Foundation funds research to block drug resistance in cancer treatment
The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has awarded a three-year grant to support research led by Houra Merrikh, PhD, professor of Biochemistry, and Ben Ho Park, MD, PhD, the Benjamin F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center, to create an anti-evolution drug to reduce the capacity of cancer cells to develop resistance. Read MoreSep 5, 2023
-
VUMC Recognized by Becker’s Hospital Review for Oncology Program
Vanderbilt University Medical Center (VUMC) has been named to the 2016 Becker’s Hospital Review list of 100 Hospitals and Health Systems with Great Oncology Programs. The annual list recognizes organizations leading the nation in cancer care. Read MoreAug 22, 2016
-
Myelosuppression unit set to move to new CCT space
New space on the 10th floor of the Critical Care Tower is allowing the myelosuppression unit to increase its number of available beds. (Photo by Susan Urmy) The 10th floor of Vanderbilt University Medical Center’s Critical Care Tower, housing a new myelosuppression unit, will open Oct. 27. Read MoreOct 18, 2012
-
HER2 may impact lung cancer therapy
A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies. Read MoreSep 21, 2012
-
‘Detangler’ binds, bends and cuts DNA
New details on the DNA-cutting activity of topoisomerase II, a target of anti-cancer drugs, could lead to better chemotherapeutic agents. Read MoreMar 2, 2012
-
New melanoma drug nearly doubles survival in majority of patients
Investigators from Vanderbilt-Ingram Cancer Center and 12 other centers in the United States and Australia have found that a new drug for patients with metastatic melanoma nearly doubled median overall survival. Read MoreFeb 23, 2012
-
Averting a future oncologist shortage
Providing increased mentorship, research opportunities and a nurturing, intellectual environment during fellowship training may help reduce a projected shortage of academic hematologists and oncologists. Read MoreNov 11, 2011
-
Stomach bugs impact nutrient levels
Helicobacter pylori, a bacterium that infects half of the world’s population and increases the risk for stomach cancer, appears to impair nutrient absorption. Read MoreJun 30, 2011
-
Protecting brainpower during radiation
Blocking a certain protein during radiation to treat brain cancers could protect the brain’s thinking powers. Read MoreJun 29, 2011